Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

GWP.L (GWP) Regulatory News

Date Source Headline
11th May 2015 3:00 pm RNS Presenting at BAML 2015 Healthcare Conference
11th May 2015 12:00 pm RNS Half Yearly Report
11th May 2015 12:00 pm RNS Initiates Ph3 Pivotal Study of Epidiolex in LGS
11th May 2015 11:45 am RNS Holding(s) in Company
11th May 2015 11:45 am RNS Holding(s) in Company
8th May 2015 4:22 pm RNS Holding(s) in Company
6th May 2015 12:00 pm RNS Notice of Results
6th May 2015 12:00 pm RNS Initiates Phase 2 Trial of CBDV in Epilepsy
6th May 2015 7:01 am RNS Closing of U.S. Public Offering of ADSs
1st May 2015 3:28 pm RNS Holding(s) in Company
1st May 2015 7:30 am RNS Holding(s) in Company
29th Apr 2015 7:00 am RNS Pricing of U.S. Public Offering of ADSs
28th Apr 2015 7:00 am RNS Proposed Public Offering of ADSs
27th Apr 2015 12:00 pm RNS US Patent Allowance for Use of Cannabidivarin
24th Apr 2015 12:00 pm RNS Orphan Drug Designation for CBD in NHIE
23rd Apr 2015 7:00 am RNS New Physician Reports of Epidiolex Treatment
21st Apr 2015 12:00 pm RNS Starts 2nd Ph 3 Epidiolex Trial in Dravet Syndrome
14th Apr 2015 7:00 am RNS New Epidiolex Data Released by AAN
1st Apr 2015 2:03 pm RNS Holding(s) in Company
31st Mar 2015 12:00 pm RNS Starts Ph 3 Trial for Epidiolex in Dravet Syndrome
17th Mar 2015 5:18 pm RNS Holding(s) in Company
17th Mar 2015 5:15 pm RNS Holding(s) in Company
25th Feb 2015 12:00 pm RNS Presenting at Upcoming Investor Conferences
17th Feb 2015 3:25 pm RNS Blocklisting Interim Review
16th Feb 2015 3:52 pm RNS Holding(s) in Company
16th Feb 2015 3:48 pm RNS Holding(s) in Company
9th Feb 2015 5:31 pm RNS Director/PDMR Shareholding
5th Feb 2015 2:25 pm RNS Result of AGM
5th Feb 2015 12:00 pm RNS Presents at Leerink Global Healthcare Conference
4th Feb 2015 12:01 pm RNS 1st Quarter Results
27th Jan 2015 7:01 am RNS Notice of Results
9th Jan 2015 4:24 pm RNS Block Listing Application
8th Jan 2015 12:00 pm RNS Update on Epidiolex Program
8th Jan 2015 12:00 pm RNS Results in Sativex Phase 3 Cancer Pain Trial
22nd Dec 2014 7:00 am RNS GW Added to NASDAQ Biotechnology Index
17th Dec 2014 6:16 pm RNS Publication of UK Annual Report and Accounts
17th Dec 2014 4:49 pm RNS Director/PDMR Shareholding
3rd Dec 2014 8:22 am RNS Holding(s) in Company
2nd Dec 2014 12:00 pm RNS Final Results
26th Nov 2014 7:00 am RNS GW Presents at Piper Jaffray Healthcare Conference
FTSE 100 Latest
Value8,809.74
Change53.53